0001299933-10-004200 Sample Contracts

INHIBITEX, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement

Inhibitex, Inc. • November 24th, 2010 • Biological products, (no disgnostic substances) • New York

• Company
  Inhibitex, Inc.
• Filed
  November 24th, 2010
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

Inhibitex, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with McNicoll, Lewis & Vlak LLC (“MLV”), as follows: